Garrett C. Moraski

2.2k total citations
35 papers, 1.6k citations indexed

About

Garrett C. Moraski is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Garrett C. Moraski has authored 35 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 23 papers in Infectious Diseases and 13 papers in Epidemiology. Recurrent topics in Garrett C. Moraski's work include Tuberculosis Research and Epidemiology (22 papers), Cancer therapeutics and mechanisms (14 papers) and Mycobacterium research and diagnosis (10 papers). Garrett C. Moraski is often cited by papers focused on Tuberculosis Research and Epidemiology (22 papers), Cancer therapeutics and mechanisms (14 papers) and Mycobacterium research and diagnosis (10 papers). Garrett C. Moraski collaborates with scholars based in United States, Singapore and Germany. Garrett C. Moraski's co-authors include Marvin J. Miller, Scott G. Franzblau, Helena I. Boshoff, Sang‐Hyun Cho, Lowell D. Markley, Philip A. Hipskind, Ute Möllmann, Tanya Parish, Patricia A. Miller and Mai A. Bailey and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Garrett C. Moraski

34 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Garrett C. Moraski United States	23	774	753	597	298	152	35	1.6k
Lluís Ballell Spain	28	701 0.9×	1.1k 1.4×	953 1.6×	553 1.9×	212 1.4×	64	2.1k
João Neres United Kingdom	21	510 0.7×	946 1.3×	647 1.1×	394 1.3×	132 0.9×	29	1.5k
E. Jeffrey North United States	19	328 0.4×	735 1.0×	942 1.6×	690 2.3×	162 1.1×	29	1.5k
William J. Suling United States	21	1.1k 1.4×	743 1.0×	498 0.8×	298 1.0×	62 0.4×	42	1.8k
Leo Einck United States	21	273 0.4×	847 1.1×	735 1.2×	519 1.7×	72 0.5×	36	1.6k
Christopher B. Cooper United States	21	502 0.6×	684 0.9×	522 0.9×	287 1.0×	80 0.5×	47	1.3k
Michio Kurosu United States	26	1.0k 1.3×	1.0k 1.4×	358 0.6×	200 0.7×	112 0.7×	85	2.1k
Cynthia S. Dowd United States	10	213 0.3×	660 0.9×	817 1.4×	563 1.9×	148 1.0×	13	1.3k
Anna M. Upton United States	26	335 0.4×	1.2k 1.6×	1.2k 2.0×	693 2.3×	209 1.4×	41	2.0k
Nicolas Willand France	20	408 0.5×	606 0.8×	411 0.7×	193 0.6×	126 0.8×	58	1.2k

Countries citing papers authored by Garrett C. Moraski

Since Specialization

Citations

This map shows the geographic impact of Garrett C. Moraski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Garrett C. Moraski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Garrett C. Moraski more than expected).

Fields of papers citing papers by Garrett C. Moraski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Garrett C. Moraski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Garrett C. Moraski. The network helps show where Garrett C. Moraski may publish in the future.

Co-authorship network of co-authors of Garrett C. Moraski

This figure shows the co-authorship network connecting the top 25 collaborators of Garrett C. Moraski. A scholar is included among the top collaborators of Garrett C. Moraski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Garrett C. Moraski. Garrett C. Moraski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Singh, Samsher, Pearly Shuyi Ng, Umayal Lakshmanan, et al.. (2026). A Series of Pyrazolo-Quinazoline Amines Inhibits the Cytochrome bd Oxidase in Mycobacterium tuberculosis. Journal of Medicinal Chemistry. 69(3). 2130–2144.

Ragunathan, Priya, Pearly Shuyi Ng, Samsher Singh, et al.. (2023). GaMF1.39’s antibiotic efficacy and its enhanced antitubercular activity in combination with clofazimine, Telacebec, ND-011992, or TBAJ-876. Microbiology Spectrum. 11(6). e0228223–e0228223. 6 indexed citations

Liu, Rui, Kate Marshall, Rui Ma, et al.. (2022). Syntheses and studies of deuterated Imdiazo[1,2-a]pyridine-3-carboxamides with potent anti-tuberculosis activity and improved metabolic properties. Bioorganic Chemistry. 128. 106074–106074. 5 indexed citations

Moraski, Garrett C., Nathalie Deboosère, Kate Marshall, et al.. (2020). Intracellular and in vivo evaluation of imidazo[2,1-b]thiazole-5-carboxamide anti-tuberculosis compounds. PLoS ONE. 15(1). e0227224–e0227224. 33 indexed citations

Moraski, Garrett C., et al.. (2019). PvdF of pyoverdin biosynthesis is a structurally unique N10-formyltetrahydrofolate-dependent formyltransferase. Archives of Biochemistry and Biophysics. 664. 40–50. 7 indexed citations

Kalia, Nitin Pal, et al.. (2019). Carbon metabolism modulates the efficacy of drugs targeting the cytochrome bc1:aa3 in Mycobacterium tuberculosis. Scientific Reports. 9(1). 8608–8608. 27 indexed citations

Scherr, Nicole, Sangeeta Susan Thomas, Aurélie Chauffour, et al.. (2018). Targeting the Mycobacterium ulcerans cytochrome bc1:aa3 for the treatment of Buruli ulcer. Nature Communications. 9(1). 5370–5370. 52 indexed citations

Streit, Bennett R., Arianna I. Celis, Garrett C. Moraski, et al.. (2018). Decarboxylation involving a ferryl, propionate, and a tyrosyl group in a radical relay yields heme b. Journal of Biological Chemistry. 293(11). 3989–3999. 22 indexed citations

Celis, Arianna I., George H. Gauss, Bennett R. Streit, et al.. (2016). Structure-Based Mechanism for Oxidative Decarboxylation Reactions Mediated by Amino Acids and Heme Propionates in Coproheme Decarboxylase (HemQ). Journal of the American Chemical Society. 139(5). 1900–1911. 42 indexed citations

10.

Moraski, Garrett C., Allen G. Oliver, Lowell D. Markley, et al.. (2014). Scaffold-switching: An exploration of 5,6-fused bicyclic heteroaromatics systems to afford antituberculosis activity akin to the imidazo[1,2-a]pyridine-3-carboxylates. Bioorganic & Medicinal Chemistry Letters. 24(15). 3493–3498. 42 indexed citations

11.

Cheng, Yong, Garrett C. Moraski, Jeffrey W. Cramer, Marvin J. Miller, & Jeffrey S. Schorey. (2014). Bactericidal Activity of an Imidazo[1, 2-a]pyridine Using a Mouse M. tuberculosis Infection Model. PLoS ONE. 9(1). e87483–e87483. 50 indexed citations

12.

Ollinger, Juliane, Mai A. Bailey, Garrett C. Moraski, et al.. (2013). A Dual Read-Out Assay to Evaluate the Potency of Compounds Active against Mycobacterium tuberculosis. PLoS ONE. 8(4). e60531–e60531. 138 indexed citations

13.

Ji, Cheng, Garrett C. Moraski, Jane A. Thanassi, et al.. (2012). Syntheses and biological studies of novel spiropiperazinyl oxazolidinone antibacterial agents using a spirocyclic diene derived acylnitroso Diels−Alder reaction. Bioorganic & Medicinal Chemistry. 20(11). 3422–3428. 6 indexed citations

14.

Moraski, Garrett C., Lowell D. Markley, Mayland Chang, et al.. (2012). Generation and exploration of new classes of antitubercular agents: The optimization of oxazolines, oxazoles, thiazolines, thiazoles to imidazo[1,2-a]pyridines and isomeric 5,6-fused scaffolds. Bioorganic & Medicinal Chemistry. 20(7). 2214–2220. 90 indexed citations

15.

Silveira, Gustavo P., Luciano Fernandes, Garrett C. Moraski, et al.. (2012). Allylic thiocyanates as a new class of antitubercular agents. Bioorganic & Medicinal Chemistry Letters. 22(20). 6486–6489. 22 indexed citations

16.

Moraski, Garrett C., Jane A. Thanassi, Steven D. Podos, Michael J. Pucci, & Marvin J. Miller. (2011). One-step syntheses of nitrofuranyl benzimidazoles that are active against multidrug-resistant bacteria. The Journal of Antibiotics. 64(10). 667–671. 11 indexed citations

17.

Moraski, Garrett C., Mayland Chang, Adriel Villegas‐Estrada, et al.. (2010). Structure–activity relationship of new anti-tuberculosis agents derived from oxazoline and oxazole benzyl esters. European Journal of Medicinal Chemistry. 45(5). 1703–1716. 108 indexed citations

18.

Miller, Marvin J., Garrett C. Moraski, & Scott G. Franzblau. (2010). Utilization of the Suzuki Coupling to Enhance the Antituberculosis Activity of Aryloxazoles. Heterocycles. 80(2). 977–977. 13 indexed citations

19.

Young, David C., Anne Kasmar, Garrett C. Moraski, et al.. (2009). Synthesis of Dideoxymycobactin Antigens Presented by CD1a Reveals T Cell Fine Specificity for Natural Lipopeptide Structures. Journal of Biological Chemistry. 284(37). 25087–25096. 22 indexed citations

20.

Miller, Marvin J., Helen He Zhu, Chunrui Wu, et al.. (2009). Utilization of microbial iron assimilation processes for the development of new antibiotics and inspiration for the design of new anticancer agents. BioMetals. 22(1). 61–75. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact